NCT02195323View on ClinicalTrials.gov

Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions
Chronic Kidney Disease
Interventions
BIOLOGICAL

Intravenous injection

Intravenous injection of bone marrow derived MSC in patients with CKD.

Trial Locations (1)

Unknown

Royan Institute, Tehran

All Listed Sponsors
lead

Royan Institute

OTHER_GOV

NCT02195323 - Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD) | Biotech Hunter | Biotech Hunter